Brentuximab Intravenous and Loteprednol and tobramycin ophthalmic
Determining the interaction of Brentuximab Intravenous and Loteprednol and tobramycin ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brentuximab
Brand name: Adcetris
Synonyms: Brentuximab vedotin, Brentuximab Vedotin
Generic Name: loteprednol / tobramycin ophthalmic
Brand name: Zylet
Synonyms: Loteprednol and tobramycin (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brentuximab Intravenous-Loteprednol Etabonate
- Brentuximab Intravenous-Loteprednol Eye Drops
- Brentuximab Intravenous-Loteprednol Eye Drops 0.2%
- Brentuximab Intravenous-Loteprednol Eye Drops 0.5% and 1%
- Brentuximab Intravenous-Loteprednol Eye Gel
- Brentuximab Intravenous-Loteprednol Eye Ointment
- Loteprednol and tobramycin ophthalmic-Brentuximab vedotin
- Loteprednol and tobramycin ophthalmic-Breo Ellipta
- Loteprednol and tobramycin ophthalmic-Brethine
- Loteprednol and tobramycin ophthalmic-Brethine Subcutaneous
- Loteprednol and tobramycin ophthalmic-Bretylium
- Loteprednol and tobramycin ophthalmic-Bretylium Injection